Evolution of the Average Target: Cardlytics, Inc.

Evolution of the Average Target - Cardlytics, Inc.

Evolution of the Target Price: Cardlytics, Inc.

Evolution of the Target Price - Cardlytics, Inc.

Changes in Analyst Recommendations: Cardlytics, Inc.

ad1bfaef7.aBBOC6Vcu6_5j3UKk8WM1eEGfsCqYH9ieDUW19C4WBc.MFkfUtJk3Ze3uBxC57zAjZBvJI3STRgRLwUv5rbwFmIhUR041jPsxrr9NA~12e8b9cae0a77a09fcc9ff1bcc6dea03
08-07 BofA Adjusts Price Target on Cardlytics to $4 From $8 MT
25-09-24 Cardlytics Shares Rise After Citron Research Says Company Has Multiple Opportunities to Rebuild MT
25-08-06 Commerce media platform Cardlytics Q2 revenue falls just shy of estimates, adjusted EBITDA positive RE
24-08-08 Lake Street Downgrades Cardlytics to Hold From Buy, Adjusts PT to $5 From $18 MT
24-08-08 Needham Downgrades Cardlytics to Hold From Buy MT
24-05-09 Craig-Hallum Adjusts Cardlytics Price Target to $12 From $18, Maintains Buy Rating MT
24-05-09 Needham Adjusts Price Target on Cardlytics to $12 From $17, Keeps Buy Rating MT
24-04-09 Needham Raises Cardlytics' Price Target to $17 From $15, Maintains Buy Rating MT
24-03-15 Craig-Hallum Upgrades Cardlytics to Buy From Hold, Adjusts Price Target to $18 From $10 MT
24-03-15 Lake Street Adjusts Cardlytics' Price Target to $18 From $13, Maintains Buy Rating MT
23-11-29 Lake Street Starts Coverage on Cardlytics with Buy Rating, $13 Price Target MT
23-08-02 Needham Adjusts Price Target on Cardlytics to $19 From $10, Maintains Buy Rating MT
23-05-05 Needham Adjusts Price Target on Cardlytics to $10 From $8, Maintains Buy Rating MT
23-04-12 Wells Fargo Adjusts Price Target on Cardlytics to $6 From $5, Keeps Underweight Rating MT
23-03-02 JPMorgan Adjusts Cardlytics Price Target to $6 From $7, Maintains Neutral Rating MT
23-03-02 Wells Fargo Adjusts Price Target on Cardlytics to $5 From $6, Keeps Underweight Rating MT
23-03-02 Needham Lowers Price Target on Cardlytics to $8 From $14, Maintains Buy Rating MT
23-01-09 Wells Fargo Adjusts Price Target on Cardlytics to $6 From $10, Maintains Underweight Rating MT
22-11-02 Needham Adjusts Price Target on Cardlytics to $14 From $19, Maintains Buy Rating MT
22-11-02 Wells Fargo Adjusts Cardlytics Price Target to $10 From $13, Maintains Underweight Rating MT
22-09-08 Wells Fargo Downgrades Cardlytics to Underweight From Equalweight, Trims Price Target to $13 From $14 MT
22-08-03 Wells Fargo Trims Cardlytics Price Target to $14 From $15, Maintains Equalweight Rating MT
22-08-03 Needham Adjusts Cardlytics' Price Target to $19 From $24, Reiterates Buy Rating MT
22-07-14 Wells Fargo Downgrades Cardlytics to Equalweight From Overweight, Adjusts Price Target to $15 From $72 MT
22-07-13 Needham Adjusts Cardlytics' Price Target to $24 from $60, Keeps Buy Rating MT

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
+191.26%
+10.53%
+2.96%
+76.52%
+7.63%
+5.59%
+0.48%
+1.95%
-8.07%
+8.2%
Average +29.71%
Weighted average by Cap. +12.91%


Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
4
Last Close Price
2.030USD
Average target price
6.000USD
Spread / Average Target
+195.57%
High Price Target
10.00USD
Spread / Highest target
+392.61%
Low Price Target
4.000USD
Spread / Lowest Target
+97.04%

Analyst Consensus Detail

Analyst consensus - Cardlytics, Inc.

Consensus revision (last 18 months)

Consensus revision (last 18 months) - Cardlytics, Inc.
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
BBB
MarketScreener Ratings - Cardlytics, Inc.
  1. Stock Market
  2. Stocks
  3. CDLX Stock
  4. Consensus Cardlytics, Inc.